Remove tag boston-scientific
article thumbnail

A history of Johnson & Johnson

pharmaphorum

Beginning in 2003, J&J became involved in a series of litigations with Boston Scientific involving patents covering heart stent medical devices. The litigation was settled in 2009, when Boston Scientific agreed to pay $716 million in September and an additional $1.73 billion the following February.

Vaccines 125